Li PP - Search Results

1

Clinical benefits as endpoints in advanced non-small cell lung cancer treated with integrative medicine.

Xue D, Li PP. Xue D, et al. Among authors: li pp. Chin J Integr Med. 2011 Mar;17(3):228-31. doi: 10.1007/s11655-011-0672-8. Epub 2011 Feb 27. Chin J Integr Med. 2011. PMID: 21359926 Review.

2

Progress of research in antitumor mechanisms with Chinese medicine.

Han SY, Li PP. Han SY, et al. Among authors: li pp. Chin J Integr Med. 2009 Aug;15(4):316-20. doi: 10.1007/s11655-009-0316-4. Epub 2009 Aug 18. Chin J Integr Med. 2009. PMID: 19688324 Review.

3

Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer.

Chen YZ, Li ZD, Gao F, Zhang Y, Sun H, Li PP. Chen YZ, et al. Among authors: li pp, li zd. Chin J Integr Med. 2009 Dec;15(6):415-9. doi: 10.1007/s11655-009-0415-2. Epub 2010 Jan 18. Chin J Integr Med. 2009. PMID: 20082245 Clinical Trial.

4

Could we use clinical benefit to evaluate the effects of chinese medicine on the treatment of cancer?

Li PP. Li PP. Chin J Integr Med. 2010 Feb;16(1):9-10. doi: 10.1007/s11655-010-0009-z. Epub 2010 Feb 4. Chin J Integr Med. 2010. PMID: 20131028 Review. No abstract available.

5

Protective effect of Renshen Yangrong Decoction (人参养荣汤) on bone marrow against radiation injury in mouse.

Chen YZ, Lin F, Zhuang GB, Ren Y, Li PP. Chen YZ, et al. Among authors: li pp. Chin J Integr Med. 2011 Jun;17(6):453-8. doi: 10.1007/s11655-011-0634-1. Epub 2011 Mar 30. Chin J Integr Med. 2011. PMID: 21465297

6

Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells.

Han SY, Zhao MB, Zhuang GB, Li PP. Han SY, et al. Among authors: li pp. Lung Cancer. 2012 Jan;75(1):30-7. doi: 10.1016/j.lungcan.2011.06.001. Epub 2011 Jul 16. Lung Cancer. 2012. PMID: 21757251

7

Anti-fatigue effect of Renshen Yangrong decoction in mice.

Chen YZ, Lin F, Li PP. Chen YZ, et al. Among authors: li pp. Chin J Integr Med. 2011 Oct;17(10):770-4. doi: 10.1007/s11655-011-0879-8. Epub 2011 Nov 19. Chin J Integr Med. 2011. PMID: 22101699

8

Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy.

Chen YZ, Li ZD, Zhou N, Sun H, Li PP. Chen YZ, et al. Among authors: li pp, li zd. Chin J Integr Med. 2012 Aug;18(8):626-8. doi: 10.1007/s11655-012-1171-2. Epub 2012 Aug 2. Chin J Integr Med. 2012. PMID: 22855039 No abstract available.

9

Long-term chinese herbs decoction administration for management of hot flashes associated with endocrine therapy in breast cancer patients.

Xue D, Sun H, Li PP. Xue D, et al. Among authors: li pp. Chin J Cancer Res. 2011 Mar;23(1):74-8. doi: 10.1007/s11670-011-0074-7. Chin J Cancer Res. 2011. PMID: 23467638 Free PMC article.

10

Immediate Versus Delayed Treatment with EGFR Tyrosine Kinase Inhibitors after First-line Therapy in Advanced Non-small-cell Lung CANCER.

Wang ZJ, An TT, Mok T, Yang L, Bai H, Zhao J, Duan JC, Wu MN, Wang YY, Li PP, Sun H, Yang P, Wang J. Wang ZJ, et al. Among authors: li pp. Chin J Cancer Res. 2011 Jun;23(2):112-7. doi: 10.1007/s11670-011-0112-5. Chin J Cancer Res. 2011. PMID: 23483659 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters